Home > Quotes > ALKS
ALKS

Alkermes plc Ordinary Shares Quote & Summary Data

$40.36
*  
0.61
1.53%
Get ALKS Alerts
*Delayed - data as of May 2, 2016  -  Find a broker to begin trading ALKS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ALKS After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Alkermes plc Ordinary Shares Intraday Chart




News for ALKS

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 40.36 $ 80.71
Low $ 38.64 $ 27.14

The current last sale of $40.36 is 48.71% Higher thanthe 52 week low.

P/E Ratio

ETFs with ALKS as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
4.27% PowerShares DWA Healthcare Momentum Portfolio (PTH) -11.55 (-20.70%)
0.39% Schwab U.S. Small-Cap ETF (SCHA) -1.22 (-2.25%)
0% QuantShares U.S. Market Neutral Momentum Fund ETF (MOM) -3.68 (-13.19%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

The following discussion contains forward­looking statements. Actual results may differ significantly from those expressed or implied in the forward­looking statements. See "Cautionary Note Concerning Forward­Looking Statements" on pages 3 and 4 of this Annual Report. Factors that might cause future results to differ materially from those expressed or implied in the forward­looking statements include, but are not limited to, those discussed in "Item 1A--Risk Factors" and elsewhere in this Annual Report. Overview Alkermes plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to research, develop and commercialize, both with partners and on its own, pharmaceutical products that are designed to address unmet medical needs of patients in major therapeutic areas.  ... More ...  

Risk Grade

Where does ALKS fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?